Search - tctmd.com

Displaying 501 - 520 of 532

Sort: Relevancy | Date

Presentation TCT Russia 2012

DES in Complex Multivessel Disease

Presenter: Gregg W. Stone

May 28, 2012

Presentation TCT Mediterranean 2012

Complex PCI: Role of IVUS and Atherectomy in Calcified Lesions

Presenter: Gregg W. Stone

May 05, 2012

Presentation TCT Mediterranean 2012

Anticoagulation in ACS: Role of Bivalirudin

Presenter: Gregg W. Stone

May 04, 2012

Presentation TCTAP 2012

The EXCEL Trial Design, Status, and Timelines

Presenter: Gregg W. Stone

April 26, 2012

Presentation TCT Russia 2012

Lessons from Pooled Data with Xience Everolimus-Eluting Stents

Presenter: Gregg W. Stone

April 26, 2012

Presentation TCTAP 2012

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Presenter: Gregg W. Stone

April 26, 2012

Presentation Fellows 2012

Bivalirudin in ACS and PCI

Presenter: Gregg Stone

April 22, 2012

Presentation Fellows 2012

Reperfusion Therapy in STEMI: Guideline, Strategies, Pharmacology, and Stent Selection

Presenter: Gregg Stone

April 21, 2012

Presentation Fellows 2012

Everolimus-Eluting Stents: Preclinical Foundation and Clinical Results

Presenter: Gregg Stone

April 21, 2012

Presentation Fellows 2012

Clinical Application of Multimodality Imaging: Vulnerable Plaque

Presenter: Gregg Stone

April 20, 2012

Presentation

Post ACC 2012 Late Breaking Trial Review

Presenter: Gregg W. Stone

April 18, 2012

Presentation

Late Breaking Trial Review

Presenter: Gregg W. Stone

April 13, 2012

Presentation ACC 2012

Two-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents in De Novo Coronary Artery Lesions

Presenter: Gregg Stone

March 28, 2012

Presentation

INFUSE-AMI

Presenter: Gregg Stone

March 25, 2012

Presentation PCI Outcomes 2012

Controversy 1: Current Drug-Eluting Stents Are Not Only More Effective But Are Safer Than Bare Metal Stents and Should Be Used in more than 90% of (Stented) Patients

Presenter: Gregg W. Stone

March 23, 2012

Presentation

New Drug-eluting Stent Designs: Are Improved Clinical Outcomes Possible?

Presenter: Gregg W. Stone

March 06, 2012

Presentation CTO 2012

The Spectrum of Two-Stent Techniques (and How to Choose)

Presenter: Gregg Stone

February 22, 2012

Presentation ISET 2012

The Use of Alternative Anticoagulants for Cardiac and Vascular Procedures

Presenter: Gregg W. Stone

January 15, 2012

Presentation ISET 2012

The Future of Plaque Differentiation: Stable versus Unstable

Presenter: Gregg W. Stone

January 15, 2012

Presentation TCT 2012

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Presenter: Jung-Won Suh, Gary S. Mintz, Giora Weisz, Akiko Maehara, Ke Xu, Alexandra J. Lansky, Ecaterina Cristea, Roxana Mehran, John McPherson, Naim Farhat, Steven P. Marso, Bernard de Bruyne, Patrick W. Serruys, Gregg W. Stone

January 03, 2012

Advertisement

DES in Complex Multivessel Disease

Complex PCI: Role of IVUS and Atherectomy in Calcified Lesions

Anticoagulation in ACS: Role of Bivalirudin

The EXCEL Trial Design, Status, and Timelines

Lessons from Pooled Data with Xience Everolimus-Eluting Stents

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Bivalirudin in ACS and PCI

Reperfusion Therapy in STEMI: Guideline, Strategies, Pharmacology, and Stent Selection

Everolimus-Eluting Stents: Preclinical Foundation and Clinical Results

Clinical Application of Multimodality Imaging: Vulnerable Plaque

Post ACC 2012 Late Breaking Trial Review

Late Breaking Trial Review

Two-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents in De Novo Coronary Artery Lesions

INFUSE-AMI

Controversy 1: Current Drug-Eluting Stents Are Not Only More Effective But Are Safer Than Bare Metal Stents and Should Be Used in more than 90% of (Stented) Patients

New Drug-eluting Stent Designs: Are Improved Clinical Outcomes Possible?

The Spectrum of Two-Stent Techniques (and How to Choose)

The Use of Alternative Anticoagulants for Cardiac and Vascular Procedures

The Future of Plaque Differentiation: Stable versus Unstable

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content